ANIK
Price:
$16.97
Market Cap:
$248.54M
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone prese...[Read more]
Industry
Medical - Devices
IPO Date
1993-05-03
Stock Exchange
NASDAQ
Ticker
ANIK
According to Anika Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.34. This represents a change of -3.44% compared to the average of 5.53 of the last 4 quarters.
The mean historical Current Ratio of Anika Therapeutics, Inc. over the last ten years is 12.29. The current 5.34 Current Ratio has changed 4.24% with respect to the historical average. Over the past ten years (40 quarters), ANIK's Current Ratio was at its highest in in the March 2015 quarter at 23.70. The Current Ratio was at its lowest in in the March 2021 quarter at 3.69.
Average
12.29
Median
12.35
Minimum
4.81
Maximum
23.27
Discovering the peaks and valleys of Anika Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 128.40%
Maximum Annual Current Ratio = 23.27
Minimum Annual Increase = -66.78%
Minimum Annual Current Ratio = 4.81
Year | Current Ratio | Change |
---|---|---|
2023 | 5.26 | -13.43% |
2022 | 6.07 | 7.38% |
2021 | 5.66 | 17.56% |
2020 | 4.81 | -66.78% |
2019 | 14.48 | -19.43% |
2018 | 17.98 | 13.90% |
2017 | 15.78 | -18.52% |
2016 | 19.37 | 89.69% |
2015 | 10.21 | -56.13% |
2014 | 23.27 | 128.40% |
The current Current Ratio of Anika Therapeutics, Inc. (ANIK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.66
5-year avg
7.26
10-year avg
12.29
Anika Therapeutics, Inc.’s Current Ratio is greater than AxoGen, Inc. (3.74), greater than Orthofix Medical Inc. (2.39), greater than Surmodics, Inc. (3.96), greater than Paragon 28, Inc. (3.50), greater than Artivion, Inc. (1.88), less than Sight Sciences, Inc. (10.18), greater than Avanos Medical, Inc. (2.22), less than OrthoPediatrics Corp. (7.17), less than NeuroPace, Inc. (5.59), less than CVRx, Inc. (11.32), greater than ProSomnus, Inc. Common Stock (0.30), less than Heska Corporation (6.70),
Company | Current Ratio | Market cap |
---|---|---|
3.74 | $587.07M | |
2.39 | $722.63M | |
3.96 | $561.12M | |
3.50 | $838.76M | |
1.88 | $1.19B | |
10.18 | $203.53M | |
2.22 | $854.80M | |
7.17 | $637.85M | |
5.59 | $289.53M | |
11.32 | $360.32M | |
0.30 | $8.18M | |
6.70 | $1.31B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anika Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anika Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Anika Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Anika Therapeutics, Inc. (ANIK)?
What is the highest Current Ratio for Anika Therapeutics, Inc. (ANIK)?
What is the 3-year average Current Ratio for Anika Therapeutics, Inc. (ANIK)?
What is the 5-year average Current Ratio for Anika Therapeutics, Inc. (ANIK)?
How does the current Current Ratio for Anika Therapeutics, Inc. (ANIK) compare to its historical average?